Suchergebnisse - "Donaldson, Eric F"

PubPharm (90)

1

Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infection

enthalten in: Journal of hepatology | 2022

von Gehring, A. | Mendez, P. | Richter, K. | +12

CommentIn: J Hepatol. 2022 Aug;77(2):299-301. - PMID 35398461

2

Communicating regulatory high-throughput sequencing data using BioCompute Objects

enthalten in: Drug discovery today | 2022

von King, C. | Keeney, J. | Guimera, N. | +8

3

Strengthening the BioCompute Standard by Crowdsourcing on PrecisionFDA

enthalten in: bioRxiv.org | 2020

von Stephens, S. | King, C. | Watford, S. | +10

4

Author Correction : A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence

enthalten in: Nature medicine | 2020

von Menachery, V. | Yount, B. | Debbink, K. | +12

ErratumFor: Nat Med. 2015 Dec;21(12):1508-13. - PMID 26552008

5

Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies

enthalten in: Virology journal | 2019

von Ilyushina, N. | Komatsu, T. | Ince, W. | +4

6

Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies

enthalten in: Virology journal | 2019

von Ilyushina, N. | Komatsu, T. | Ince, W. | +4

7

Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies

enthalten in: Virology journal | 2019

von Ilyushina, N. | Komatsu, T. | Ince, W. | +4

8

In-depth genomic analyses identified novel letermovir resistance-associated substitutions in the cytomegalovirus UL56 and UL89 gene products

enthalten in: Antiviral research | 2019

von Komatsu, T. | Hodowanec, A. | Colberg-Poley, A. | +4

9

2018 Ebola virus disease outbreak in Équateur Province, Democratic Republic of the Congo : a retrospective genomic characterisation

enthalten in: The Lancet. Infectious diseases | 2019

von Mbala-Kingebeni, P. | Pratt, C. | Wiley, M. | +37

CommentIn: Lancet Infect Dis. 2019 Jun;19(6):567-568. - PMID 31000466

10

Impact of hepatitis C virus polymorphisms on direct-acting antiviral treatment efficacy : Regulatory analyses and perspectives

enthalten in: Hepatology (Baltimore, Md.) | 2018

von Harrington, P. | Komatsu, T. | Deming, D. | +3

1
2
3
4
5
6
7
8
9
Nächster »
[9]